MS Drug Takes a Feisty Approach Aimed at Younger Patients

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

MS Drug Takes a Feisty Approach Aimed at Younger Patients

Post by MSUK »

An MS Drug Takes a Feisty Approach Aimed at Younger Patients

The Swiss drug maker Novartis is taking a sassy new tack to win converts to its oral multiple sclerosis treatment, Gilenya. Its “Hey MS, Take This!” campaign shows patients sticking out their tongues with Gilenya capsules on them to show their willingness to fight back against the neurological condition..... Read More - http://www.ms-uk.org/index.cfm/MSnews
MS-UK - http://www.ms-uk.org/
Top
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Gilenya”